Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 78Observational 2

Sponsor

Cancer Type

CNS 24Gastrointestinal 22Breast 19Genitourinary 18Thoracic 11Gynecologic 9Tumor-Agnostic 6Lymphoid 6Endocrine 6Head & Neck 4Plasma cell 3Other hematologic neoplasm 3NET 3Sarcoma 2Dermatologic 2Myeloid 1

Conditions

Sarcoma 1Gliosarcoma 1Glioblastoma 1Brain Neoplasms 1

Interventions

Blood Specimen Collection 14Surveys and Questionnaires 13Surgical Procedures, Operative 12Gene Expression Profiling 10Observation 7Amplified Fragment Length Polymorphism Analysis 7Polymerase Chain Reaction 6Drug Therapy 6Radiotherapy 5Microarray Analysis 5Immunohistochemistry 5Psychiatric Rehabilitation 4Imatinib Mesylate 4Base Sequence 4regorafenib 3Trabectedin 3Tissue Banks 3Therapeutics 3Sunitinib 3Specimen Handling 3Reverse Transcriptase Polymerase Chain Reaction 3Radiation 3Methods 3Magnetic Resonance Imaging 3Interviews as Topic 3Doxorubicin 3Biopsy 3ripretinib 2mifamurtide 2Watchful Waiting 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Magnetic Resonance Spectroscopy × Sarcoma × Clear all
NCT05560009 2025-07-10

An Imaging Agent (Fluorodopa F 18) With Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Treatment Response in Patients With High-Grade Soft Tissue Sarcomas

Mayo Clinic

Completed
9 enrolled
Sarcoma

Sarcoma

NCT00777686 2012-03-30

Measuring Non-Enhancing Glioblastoma Progression

M.D. Anderson Cancer Center

Completed
7 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡